Acute Glomerular Nephritis - Nursing Case Study
Pathophysiology
• Primary mechanism: Acute Glomerular Nephritis (AGN) often arises from an immune response, typically post-streptococcal infection, where antigen-antibody complexes deposit in the glomeruli, triggering inflammation. This inflammatory reaction causes swelling and damage to the glomerular membrane, impairing filtration.
• Secondary mechanism: The inflammatory process increases glomerular permeability, allowing proteins and red blood cells to leak into the urine (proteinuria and hematuria). This results in decreased oncotic pressure and potential fluid overload, contributing to edema.
• Key complication: The impaired filtration and fluid imbalance can lead to hypertension and, if untreated, may progress to acute kidney injury, necessitating vigilant monitoring and intervention to prevent chronic kidney damage.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes
• Current medications: Lisinopril, Metformin, Insulin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Swelling and decreased urine output
• Key symptoms: Hematuria, fatigue, headache, nausea
• Vital signs: Blood pressure 160/100 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C
Section 1
New Diagnostic Results:
Following the initial presentation, a series of diagnostic tests were conducted to further evaluate the extent of the kidney involvement and to guide subsequent management strategies. Laboratory results revealed significant proteinuria with a urine protein-to-creatinine ratio of 4.2 g/g, confirming the loss of substantial protein through the urine. Serum creatinine levels were elevated at 2.1 mg/dL, indicating a decline in renal function from his baseline. Additionally, low serum albumin levels at 2.8 g/dL suggested hypoalbuminemia, contributing to the patient's edema. An antistreptolysin O (ASO) titer was also elevated, corroborating a recent streptococcal infection as a possible trigger for the acute glomerular nephritis.
A renal ultrasound was performed to rule out any obstructive causes and revealed kidneys of normal size but with increased echogenicity, consistent with the glomerular inflammation observed in AGN. Blood tests showed worsening anemia with hemoglobin at 9.5 g/dL, likely due to the combined effects of inflammation and the kidney's impaired erythropoietin production. Electrolyte imbalances were noted, with hyperkalemia at 5.8 mmol/L, posing a risk for cardiac complications. These findings underscore the need for prompt intervention to manage fluid overload, protect renal function, and correct metabolic derangements.
These diagnostic results point to an exacerbation of the patient's condition, necessitating a multi-faceted approach to treatment. The healthcare team must focus on managing the hypertension, potentially adjusting the patient's antihypertensive regimen, and closely monitoring electrolyte levels to prevent further complications. The elevated creatinine and proteinuria indicate a need for careful fluid management, possibly considering diuretics while monitoring kidney function closely. These interventions, paired with dietary modifications and continued monitoring, will be crucial in preventing the progression to more severe renal impairment and associated systemic complications.
Section 2
Change in Patient Status:
Over the next 48 hours, the patient exhibited several changes in clinical status that required immediate attention and adjustment of the treatment plan. The most pressing development was the emergence of worsening edema, now presenting as generalized anasarca. The patient's weight increased by 3 kg, and he reported escalating discomfort and shortness of breath, particularly when lying flat, suggesting the onset of pulmonary edema. Auscultation of the lungs revealed bilateral crackles, predominantly at the lung bases, indicating fluid accumulation. Vital signs showed hypertension with blood pressure readings climbing to 160/100 mmHg, despite ongoing antihypertensive therapy.
Laboratory monitoring revealed that serum potassium levels further increased to 6.2 mmol/L, heightening the risk of cardiac arrhythmias. Electrocardiogram (ECG) changes consistent with hyperkalemia, such as peaked T waves, were observed, necessitating urgent intervention. Additionally, repeat serum creatinine levels rose to 2.5 mg/dL, signaling a rapid decline in renal function. The patient's urine output decreased significantly, raising concerns about acute kidney injury and fluid overload. These findings prompted the healthcare team to reassess the patient's treatment regimen, considering the addition of loop diuretics to address fluid overload while ensuring close monitoring of renal function and electrolytes.
In response to these developments, the clinical team initiated a stepwise approach to address the emergent complications. They adjusted the antihypertensive regimen to include an angiotensin-converting enzyme (ACE) inhibitor, aiming to reduce proteinuria and provide renal protection. To address hyperkalemia, measures such as administration of calcium gluconate, insulin with glucose, and potentially sodium polystyrene sulfonate were implemented to stabilize cardiac membranes and facilitate potassium redistribution. The patient's dietary plan was revised to include strict sodium and potassium restrictions, emphasizing the importance of dietary compliance in managing the condition. These interventions were coupled with increased monitoring of vital signs, fluid balance, and serial laboratory assessments to evaluate treatment efficacy and adjust the management plan as needed.
Section 3
Response to Interventions:
Over the following 24 hours, the clinical interventions began to yield measurable outcomes. The administration of loop diuretics, coupled with dietary modifications, initiated a gradual reduction in the patient's generalized edema. The patient's weight decreased by 1.5 kg, indicating effective diuresis. Subjectively, the patient reported slight relief in dyspnea, particularly when resting in a semi-upright position, suggesting an improvement in pulmonary congestion. Reassessment of lung sounds revealed diminished crackles at the bases, a positive sign of fluid reduction in the lungs.
Laboratory results showed a slight improvement in renal function, with serum creatinine levels decreasing to 2.3 mg/dL, reflecting a positive response to the adjusted treatment plan. Importantly, serum potassium levels decreased to 5.5 mmol/L following the combined interventions of insulin, glucose, and sodium polystyrene sulfonate. The ECG showed normalization of T wave morphology, reducing the immediate risk of arrhythmias. Blood pressure readings showed a gradual decrease to 150/95 mmHg, indicating partial efficacy of the modified antihypertensive regimen.
Despite these encouraging developments, the clinical team remained vigilant, aware of the potential for new complications. Continued close monitoring of fluid status, renal function, and electrolytes was emphasized, recognizing the fragile balance in managing acute glomerular nephritis with concurrent acute kidney injury. The team planned for additional adjustments based on ongoing assessments, including the potential need for further escalation of diuretic therapy or the introduction of renal replacement therapy should renal function fail to stabilize. This cautious yet proactive approach aimed to prevent further deterioration and guide the patient toward recovery.
Section 4
New Complications:
As the clinical team continued to monitor the patient, a new complication emerged that required immediate attention. Approximately 36 hours into the treatment regimen, the patient began experiencing increased fatigue and muscle weakness, symptoms that were initially attributed to general illness. However, a subsequent laboratory workup revealed a notable drop in serum potassium levels to 3.2 mmol/L, indicating the development of hypokalemia. This unexpected shift in electrolytes was a direct consequence of aggressive diuretic therapy, which had effectively reduced edema but also inadvertently depleted the patient's potassium reserves.
In addition to the electrolyte imbalance, the patient also exhibited signs of worsening azotemia, with blood urea nitrogen (BUN) levels rising to 45 mg/dL. This was concerning for potential pre-renal azotemia, possibly due to over-diuresis or inadequate renal perfusion. The patient's blood pressure, which had previously shown improvement, was now recorded at 130/85 mmHg, signaling a further decrease that warranted attention to ensure it did not fall too low, compromising renal perfusion. The patient’s urine output decreased slightly, prompting the clinical team to reassess fluid management strategies to balance the need for diuresis with the risk of further renal impairment.
In response to these developments, the healthcare team promptly adjusted the treatment plan. Potassium supplements were introduced to correct the hypokalemia, and the dose of diuretics was carefully titrated to prevent further electrolyte disturbances. The decision was made to closely monitor the patient's hemodynamics and renal function, with a plan for potential intravenous hydration to support renal perfusion if necessary. These adjustments highlighted the complexity of managing acute glomerular nephritis with concurrent acute kidney injury, underscoring the importance of vigilant monitoring and dynamic treatment strategies to navigate new complications and guide the patient towards recovery.
Section 5
As the healthcare team continued to navigate the complexities of the patient's condition, a change in patient status became evident 24 hours after the adjustment of the treatment regimen. The patient reported feeling slightly less fatigued, and muscle strength showed marginal improvement, indicating a positive response to the potassium supplementation. Serum potassium levels, upon re-evaluation, had risen to 3.8 mmol/L, within the lower end of the normal range, suggesting that the hypokalemia was being effectively addressed.
However, the patient's renal function continued to present challenges. Despite the revised diuretic strategy and cautious fluid management, the patient’s urine output remained suboptimal, and creatinine levels had increased to 2.3 mg/dL from a previous 1.9 mg/dL. These findings pointed to a potential progression of acute kidney injury, requiring further investigation to delineate between intrinsic renal damage and reversible causes such as fluid imbalance. Blood pressure stabilized at 125/80 mmHg, maintaining renal perfusion without further hypotensive episodes, but vigilance was necessary to ensure it remained within a safe range.
These developments prompted the clinical team to consider additional diagnostic testing, including a renal ultrasound to assess for any structural abnormalities or obstructions contributing to the worsening azotemia. The team also contemplated the potential need for nephrology consultation to evaluate the necessity of more advanced interventions, such as temporary renal replacement therapy, should the patient’s renal function continue to decline. This scenario underscored the importance of timely reassessment and adaptation of the treatment plan, emphasizing the need for a nuanced understanding of the interplay between electrolyte management, fluid balance, and renal function in patients with acute glomerular nephritis.